Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium

BACKGROUND: Guidelines recommend omalizumab in patients with uncontrolled severe allergic asthma. We investigated real-life use of omalizumab, the proportion of patients fulfilling eligibility criteria, its costs and its effectiveness. METHOD: In a cohort of asthma patients initiating treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhamme, Katia M.C., Lucet, Catherine, Van Meerhaeghe, Alain, Brusselle, Guy G.O., Lambert, Marie-Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876130/
https://www.ncbi.nlm.nih.gov/pubmed/31777749
http://dx.doi.org/10.1183/23120541.00253-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876130/
https://www.ncbi.nlm.nih.gov/pubmed/31777749
http://dx.doi.org/10.1183/23120541.00253-2018

Ejemplares similares